Chiesi Group appointed Maria Paola Chiesi as the new Chair of its Board of Directors in Parma, Italy.
This leadership transition is designed to ensure continuity within the family-owned business while embedding sustainability as a central pillar of the company's long-term strategy. By shifting roles at the top, the group aims to maintain responsible governance across generations.
Maria Paola Chiesi succeeds Alessandro Chiesi, who is stepping down from the position [1]. Alessandro Chiesi served as the Chair for nearly three years [1].
The company said the change is part of a broader effort to reflect the Chiesi family's commitment to shared value [2]. This transition focuses on reinforcing the group's ability to evolve while remaining anchored in its core family principles, a move the company said will support its ongoing growth.
Reports on the full scope of the transition vary. Some sources said that the company announced both a new Chair and a new Vice Chair [2]. Other reports mention only the appointment of the Chair and do not name a Vice Chair [1].
Based in Parma, the group continues to operate as a privately held entity driven by family leadership [2]. The shift in the Board of Directors comes as the company seeks to integrate more sustainable practices into its global operations [2].
“Maria Paola Chiesi succeeds Alessandro Chiesi, who is stepping down from the position.”
The appointment of Maria Paola Chiesi signals a strategic pivot toward sustainability-led governance. By rotating leadership within the family, Chiesi Group is attempting to balance the stability of a legacy business with the modern requirement for environmental and social responsibility in the pharmaceutical sector.
